← Back to Search

Behavioural Intervention

iCOSMO for Stroke (iCOSMO Trial)

N/A
Waitlist Available
Led By Mark Bayley, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Clinical diagnosis of stroke
* Must be more than 6 months post-stroke
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, immediately after intervention,1-month
Awards & highlights

Summary

The iCOSMO study investigates the feasibility and beneficial effects of an intervention combining sensation, motor and cognition to improve arm and hand function after chronic stroke.

Who is the study for?
The iCOSMO trial is for individuals who have had a stroke and are looking to improve the function of their arm and hand. Specific eligibility criteria details were not provided.
What is being tested?
This study tests two types of training programs: GRASP, which patients do at home, and iCOSMO, which integrates sensory, motor, and cognitive exercises to aid recovery after a chronic stroke.
What are the potential side effects?
Potential side effects are not detailed in the information provided but may include muscle soreness or fatigue due to exercise-based interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, immediately after intervention,1-month
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediately after intervention,1-month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Action Research Arm Test (ARAT)
Box and Block Test (BBT)
Fidelity
+14 more
Secondary study objectives
Pain visual analogue scale (PVAS)
Stanford Fatigue Visual Analogue Scale (SFVAS)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: iCOSMOExperimental Treatment1 Intervention
20 participants will receive the iCOSMO intervention. iCOSMO consists of two training approaches that will include active touch and movement exploratory procedures during goal-oriented tasks as well as robotic training using the Kinarm Exoskeleton device.
Group II: Home GRASPActive Control1 Intervention
20 participants will receive the control intervention. The control group will receive a matched dose of a home-based exercise programme. The home-based exercise programme will be based on the Home Graded Repetitive Arm Supplementary Program.

Find a Location

Who is running the clinical trial?

StrokeCog clinical training platformUNKNOWN
University Health Network, TorontoLead Sponsor
1,513 Previous Clinical Trials
499,845 Total Patients Enrolled
25 Trials studying Stroke
5,571 Patients Enrolled for Stroke
Mark Bayley, MDPrincipal InvestigatorToronto Rehabilitation Institute
6 Previous Clinical Trials
592 Total Patients Enrolled
3 Trials studying Stroke
243 Patients Enrolled for Stroke
~27 spots leftby Jul 2027